Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 2/20 | 0.81 |
| ▸ | LMNA | P02545 | 2/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.81 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.81 |
| ▸ | PRKCG | P05129 | 1/20 | 0.81 |
| ▸ | PRKCB | P05771 | 1/20 | 0.81 |
| ▸ | PRKCA | P17252 | 1/20 | 0.81 |
| ▸ | PRKCH | P24723 | 1/20 | 0.81 |
| ▸ | PRKCI | P41743 | 1/20 | 0.81 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.81 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.81 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.81 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.81 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.81 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.81 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.81 |
| ▸ | MEN1 | O00255 | 1/20 | 0.81 |
| ▸ | GMNN | O75496 | 1/20 | 0.81 |
| ▸ | BLM | P54132 | 1/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10755721 | 1.00 | AKT1 (0.81) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL1532761 | 0.99 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL2582886 | 0.99 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL2734265 | 0.99 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL10602960 | 0.99 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL417053 | 0.99 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL2733343 | 0.99 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL4320248 | 0.99 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL10565746 | 0.99 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG | |
| SCHEMBL10564175 | 0.99 | AKT1 (0.83) | AKT1LMNAALDH1A1PRKD3PRKCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 814 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118103367-A | Acid-labile chemotherapeutic paclitaxel compounds for the treatment of cancer | 威尔德医疗有限公司 | 2024-05-28 | — | — | CN | claimed |
| EP-4355744-A1 | ACID-LABILE CHEMOTHERAPEUTIC PACLITAXEL BASED COMPOUNDS FOR THE TREATMENT OF CANCER | Veiled Therapeutics LLC (US) | 2024-04-24 | — | — | EP | claimed |
| CN-117442731-A | Application of SHP2 inhibitor in preparation of medicine for treating chronic thromboembolism | 浙江大学医学院附属邵逸夫医院 | 2024-01-26 | — | — | CN | claimed |
| WO-2024014511-A1 | LIPID NANOPARTICLE AND METHOD FOR PRODUCING SAME, NUCLEIC ACID-ENCAPSULATED LIPID NANOPARTICLE AND METHOD FOR PRODUCING SAME, AND METHOD FOR INDUCING ACQUIRED IMMUNITY IN LIVING BODY BY USING NUCLEIC ACID-ENCAPSULATED LIPID NANOPARTICLE | 日油株式会社 | 2024-01-18 | — | — | WO | claimed |
| US-20230347016-A1 | VALVE MATERIAL WITH LONG-ACTING ANTITHROMBOSIS PROPERTY AND PREPARATION METHOD THEREFOR | VENUS MEDTECH (HANGZHOU) INC. (CN) | 2023-11-02 | — | — | US | claimed |
| WO-2023190175-A1 | LIPID NANOPARTICLES FOR DELIVERING NUCLEIC ACID TO PERIPHERAL BLOOD MONONUCLEAR CELLS, AND METHOD FOR DELIVERING NUCLEIC ACID TO PERIPHERAL BLOOD MONONUCLEAR CELLS USING SAME | 日油株式会社 | 2023-10-05 | — | — | WO | claimed |
| WO-2023190176-A1 | LIPID NANOPARTICLES FOR DELIVERING NUCLEIC ACID TO SPLENIC TISSUE, AND METHOD FOR DELIVERING NUCLEIC ACID TO SPLENIC TISSUE USING SAME | 日油株式会社 | 2023-10-05 | — | — | WO | claimed |
| CN-115353616-B | Pegylated lipid | 厦门赛诺邦格生物科技股份有限公司 | 2023-03-07 | — | — | CN | claimed |
| EP-4137168-A1 | VALVE MATERIAL HAVING LONG-ACTING ANTITHROMBOSIS PROPERTY AND PREPARATION METHOD THEREFOR | Venus MedTech (HangZhou), Inc. (CN) | 2023-02-22 | — | — | EP | claimed |
| US-20230035723-A1 | Treatment of Pancreatic Cancer | SYNCORE BIOTECHNOLOGY CO., LTD. (TW) | 2023-02-02 | — | — | US | claimed |
| EP-1444991-A1 | Novel targeted compositions for diagnostic and therapeutic use | IMARX PHARMACEUTICAL CORP. (US) | 2004-08-11 | — | — | EP | claimed |
| US-20020028474-A1 | Composition for immunohistochemical staining | DAIICHI PURE CHEMICAL CO., LTD. (JP) | 2002-03-07 | — | — | US | claimed |
| EP-0831932-A4 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP (US) | 2000-01-12 | — | — | EP | claimed |
| EP-0935139-A1 | IMMUNOHISTOCHEMICAL STAINING COMPOSITION | DAIICHI PURE CHEMICALS CO., LTD. (JP) | 1999-08-11 | — | — | EP | claimed |
| EP-0831932-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1998-04-01 | — | — | EP | claimed |
| WO-1996040285-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1996-12-19 | — | — | WO | claimed |
| US-4814112-A | Single-stage process for preparing mixed-substituted 1,2-diacyl-sn-clycero-3-phosphocholines | CL PHARMA AKTIENGESELLSCHAFT (AT) | 1989-03-21 | — | — | US | claimed |
| EP-0161519-B1 | DERIVATIVES OF GLYCEROPHOSPHOCHOLINE AND OF GLYCEROPHOSPHOETHANOL AMINE, THEIR PREPARATION AND USE | CHEMIE LINZ AKTIENGESELLSCHAFT (AT) | 1988-06-29 | — | — | EP | claimed |
| US-4717512-A | Preparation of acylated glycerophosphocholines and glycerophosphoethanolamines | CHEMIE LINZ AKTIENGESELLSCHAFT (AT) | 1988-01-05 | — | — | US | claimed |
| EP-0161519-A2 | Derivatives of glycerophosphocholine and of glycerophosphoethanol amine, their preparation and use | CHEMIE LINZ AKTIENGESELLSCHAFT (AT) | 1985-11-21 | — | — | EP | claimed |